Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2002
12/12/2002US20020186450 Photochromic gyricon display
12/12/2002CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002CA2449770A1 Novel anti-infectives
12/12/2002CA2449077A1 Epothilone derivatives
12/12/2002CA2447480A1 Pyranoindazoles and their use for the treatment of glaucoma
12/12/2002CA2447156A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002EP1264597A2 Methods and compositions for treating cancer
12/11/2002EP1263723A1 Ningalin b analogs employable for reversing multidrug resistance
12/11/2002EP1131325B1 [pyrrole]naphthopyranes, their preparation, compositions and (co)polymer matrices containing them
12/11/2002EP1100805B1 Medicine nitrate salts
12/11/2002EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/11/2002EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/11/2002CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
12/10/2002US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002US6492358 For treatment of sexual disorders, male erectile dysfunction
12/10/2002US6492335 Glycoconjugates from modified camptothecin derivatives (20-O-linkage)
12/10/2002US6491749 Fluorescent dyes having good fastness to heat and to light
12/09/2002WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002WO2002096912A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy
12/05/2002WO2002096908A1 Antibacterial agents
12/05/2002WO2002096881A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
12/05/2002WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002WO2002096359A2 Piperazine pentanamide hiv protease inhibitors
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002US20020183369 For therapy of diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis
12/05/2002US20020183355 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
12/05/2002US20020183352 Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
12/05/2002US20020183351 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002US20020183346 Tricyclic androgen receptor modulator compounds and methods
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002US20020183341 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
12/05/2002US20020183331 For therapy of schizophrenia, schizoaffective disorder, bipolar disorder, Parkinson's disease, L-DOPA induced psychoses or dyskinesias, Tourette's syndrome, hyperprolactinemia, or addiction to ethanol, nicotine, cocaine
12/05/2002US20020183330 For therapy of schizophrenia, schizoaffective disorder, bipolar disorder, Parkinson's disease, L-DOPA induced psychoses or dyskinesias, Tourette's syndrome, hyperprolactinemia, or addiction to ethanol, nicotine, cocaine
12/05/2002US20020183329 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
12/05/2002US20020183309 For therapy of acute myocardial infarction, asthma, bipolar disorder, cognitive enhancement, cognitive deficits in psychiatric disorders, cutaneous carcinoma, drug abuse, depression, gastrointestinal disorders, inflammation
12/05/2002US20020183307 For therapy of hyperlipidemic condition
12/05/2002US20020182232 Naphthofurandione dyes
12/05/2002DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases
12/05/2002CA2750876A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 5-carboxamide
12/05/2002CA2455341A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy
12/05/2002CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002CA2446697A1 Antibacterial agents
12/04/2002EP1262817A1 Photochromic gyricon display
12/04/2002EP1262177A2 Medical use of thyromimetic compounds to treat hair loss and compositions
12/04/2002EP1261625A2 Memno peptides, a process for their preparation and their use
12/04/2002EP1077967B1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/04/2002EP0802915B1 Camptothecin derivatives and its manufacturing method
12/03/2002US6489492 Disodium(2s,3s)-tetrahydro-3-hydroxy-5-oxo-2,3-furandicarboxylate for example, as well as corresponding acyl halides, esters, cyclic imides, and protected hydroxyl derivates thereof
12/03/2002US6489314 Due to the increasing interest in epothilones as anti-cancer agents, novel derivatives of these compounds are needed and desired to more fully develop their therapeutic potential
12/03/2002CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents
11/2002
11/28/2002WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002WO2002094844A2 Antiviral nucleosides
11/28/2002WO2002094840A2 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094835A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094825A1 Novel spiropiperidine derivative
11/28/2002WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002WO2002094789A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002WO2002094311A1 Use of proteasome inhibitors to treat dry eye disorders
11/28/2002US20020177707 Aminoaryl oxazolidinone n-oxides
11/28/2002US20020177615 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
11/28/2002US20020177609 Fatty alcohol drug conjugates
11/28/2002US20020177589 Novel amines as histamine-3 receptor ligands and their therapeutic applications
11/28/2002US20020177588 Selectivity
11/28/2002US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002CA2826505A1 Antiviral nucleosides
11/28/2002CA2448197A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2448191A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002CA2446620A1 Antiviral nucleosides
11/28/2002CA2446324A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002EP1259484A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0900023B1 Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators
11/27/2002EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/27/2002CN1094939C Microbiocidal benzotriazoles compounds, making method and use
11/27/2002CN1094927C Process for preparing 2-azadihydroxybicyclo [2,2,1] heptane compounds and L-tartaric acid salt of the compound
11/26/2002US6486343 Substituted phenyl keto enols as pesticides and herbicides
11/26/2002US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002US6486320 Preparation of camptothecin and of its derivatives
11/26/2002US6486199 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/26/2002US6486191 Fungicidal activity
11/26/2002US6486171 Useful in the treatment of some central nervous system disorders including as an antidepressant; 4-(1-(2-naphthyl)ethyl)-4- piperidinyl)thieno(3,2-c)pyridine, for example